Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2+ Monocytes.

Johndrow CT, Goldberg MF, Johnson AJ, Ng TW, Kunnath-Velayudhan S, Lauvau G, Kaplan DH, Gossel GH, Kadolsky UD, Yates AJ, Chan J, Jacobs WR Jr, Porcelli SA.

J Immunol. 2018 Dec 15;201(12):3604-3616. doi: 10.4049/jimmunol.1801185. Epub 2018 Nov 19.

PMID:
30455402
2.

Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.

Venkataswamy MM, Baena A, Goldberg MF, Bricard G, Im JS, Chan J, Reddington F, Besra GS, Jacobs WR Jr, Porcelli SA.

J Immunol. 2009 Aug 1;183(3):1644-56. doi: 10.4049/jimmunol.0900858.

3.

Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.

Trujillo-Vargas CM, Mayer KD, Bickert T, Palmetshofer A, Grunewald S, Ramirez-Pineda JR, Polte T, Hansen G, Wohlleben G, Erb KJ.

Clin Exp Allergy. 2005 Aug;35(8):1003-13.

PMID:
16120081
4.

PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2.

Xu Y, Yang E, Huang Q, Ni W, Kong C, Liu G, Li G, Su H, Wang H.

J Mol Med (Berl). 2015 Jun;93(6):645-62. doi: 10.1007/s00109-014-1243-1. Epub 2015 Jan 15.

PMID:
25586105
5.

Routing dependent immune responses after experimental R848-adjuvated vaccination.

van Aalst S, Jansen MAA, Ludwig IS, van der Zee R, van Eden W, Broere F.

Vaccine. 2018 Mar 7;36(11):1405-1413. doi: 10.1016/j.vaccine.2018.01.077.

6.

Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells.

von Meyenn F, Schaefer M, Weighardt H, Bauer S, Kirschning CJ, Wagner H, Sparwasser T.

Immunobiology. 2006;211(6-8):557-65. Epub 2006 Jul 5.

PMID:
16920494
7.

TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.

Duraisingham SS, Hornig J, Gotch F, Patterson S.

J Immunol. 2009 Aug 15;183(4):2242-51. doi: 10.4049/jimmunol.0900474. Epub 2009 Jul 22.

8.

Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.

Gupta N, Vedi S, Kunimoto DY, Agrawal B, Kumar R.

Vaccine. 2016 Nov 4;34(46):5677-5688. doi: 10.1016/j.vaccine.2016.08.075. Epub 2016 Sep 29.

PMID:
27693020
9.

Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.

Dowling DJ, Scott EA, Scheid A, Bergelson I, Joshi S, Pietrasanta C, Brightman S, Sanchez-Schmitz G, Van Haren SD, Ninković J, Kats D, Guiducci C, de Titta A, Bonner DK, Hirosue S, Swartz MA, Hubbell JA, Levy O.

J Allergy Clin Immunol. 2017 Nov;140(5):1339-1350. doi: 10.1016/j.jaci.2016.12.985. Epub 2017 Mar 23.

10.

Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9.

Simmons DP, Canaday DH, Liu Y, Li Q, Huang A, Boom WH, Harding CV.

J Immunol. 2010 Aug 15;185(4):2405-15. doi: 10.4049/jimmunol.0904005. Epub 2010 Jul 21.

11.

The Combination of MBP and BCG-Induced Dendritic Cell Maturation through TLR2/TLR4 Promotes Th1 Activation In Vitro and Vivo.

Jiang L, Liu G, Ni W, Zhang N, Jie J, Xie F, Tai G.

Mediators Inflamm. 2017;2017:1953680. doi: 10.1155/2017/1953680. Epub 2017 Feb 15.

12.

Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production.

Martino A, Badell E, Abadie V, Balloy V, Chignard M, Mistou MY, Combadière B, Combadière C, Winter N.

J Immunol. 2010 Feb 15;184(4):2038-47. doi: 10.4049/jimmunol.0903348. Epub 2010 Jan 18.

13.

Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.

Uehori J, Matsumoto M, Tsuji S, Akazawa T, Takeuchi O, Akira S, Kawata T, Azuma I, Toyoshima K, Seya T.

Infect Immun. 2003 Aug;71(8):4238-49.

14.

The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.

Halliday A, Turner JD, Guimarães A, Bates PA, Taylor MJ.

Parasit Vectors. 2016 Feb 20;9:96. doi: 10.1186/s13071-016-1381-0.

15.

Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.

Uyangaa E, Choi JY, Patil AM, Hossain FMA, Park SO, Kim B, Kim K, Eo SK.

Front Immunol. 2018 Apr 30;9:905. doi: 10.3389/fimmu.2018.00905. eCollection 2018.

16.

Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.

Kamath AT, Rochat AF, Valenti MP, Agger EM, Lingnau K, Andersen P, Lambert PH, Siegrist CA.

PLoS One. 2008;3(11):e3683. doi: 10.1371/journal.pone.0003683. Epub 2008 Nov 10.

17.

High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.

Hervas-Stubbs S, Majlessi L, Simsova M, Morova J, Rojas MJ, Nouzé C, Brodin P, Sebo P, Leclerc C.

Infect Immun. 2006 Jun;74(6):3396-407.

18.

Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut.

Obieglo K, Feng X, Bollampalli VP, Dellacasa-Lindberg I, Classon C, Österblad M, Helmby H, Hewitson JP, Maizels RM, Gigliotti Rothfuchs A, Nylén S.

J Immunol. 2016 Mar 1;196(5):2262-71. doi: 10.4049/jimmunol.1500970. Epub 2016 Jan 27.

19.

TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis.

Reba SM, Li Q, Onwuzulike S, Ding X, Karim AF, Hernandez Y, Fulton SA, Harding CV, Lancioni CL, Nagy N, Rodriguez ME, Wearsch PA, Rojas RE.

Eur J Immunol. 2014 May;44(5):1410-21. doi: 10.1002/eji.201344100. Epub 2014 Mar 14.

20.

Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis.

Jaron B, Maranghi E, Leclerc C, Majlessi L.

PLoS One. 2008 Jul 30;3(7):e2833. doi: 10.1371/journal.pone.0002833.

Supplemental Content

Support Center